Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs.
暂无分享,去创建一个
Artem Cherkasov | Kai Hilpert | Håvard Jenssen | Christopher D Fjell | Matt Waldbrook | Sarah C Mullaly | Rudolf Volkmer | Robert E W Hancock | C. Fjell | R. Hancock | S. Mullaly | R. Volkmer | A. Cherkasov | K. Hilpert | H. Jenssen | Matthew Waldbrook
[1] C. Fjell,et al. Identification of novel antibacterial peptides by chemoinformatics and machine learning. , 2009, Journal of medicinal chemistry.
[2] Håvard Jenssen,et al. Novel anti-infectives: is host defence the answer? , 2008, Current opinion in biotechnology.
[3] Artem Cherkasov,et al. QSAR modeling and computer‐aided design of antimicrobial peptides , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[4] Artem Cherkasov,et al. Evaluating Different Descriptors for Model Design of Antimicrobial Peptides with Enhanced Activity Toward P. aeruginosa , 2007, Chemical biology & drug design.
[5] Kai Hilpert,et al. Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology , 2007, Nature Protocols.
[6] Kai Hilpert,et al. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion , 2007, Nature Protocols.
[7] Oreola Donini,et al. An anti-infective peptide that selectively modulates the innate immune response , 2007, Nature Biotechnology.
[8] P. Kubes,et al. The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands1 , 2006, The Journal of Immunology.
[9] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[10] Thomas Engel,et al. Basic Overview of Chemoinformatics , 2006, J. Chem. Inf. Model..
[11] Gregory Stephanopoulos,et al. A linguistic model for the rational design of antimicrobial peptides , 2006, Nature.
[12] Kai Hilpert,et al. Sequence requirements and an optimization strategy for short antimicrobial peptides. , 2006, Chemistry & biology.
[13] Vladimir Frecer,et al. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. , 2006, Bioorganic & medicinal chemistry.
[14] Artem Cherkasov,et al. Comparative QSAR- and Fragments Distribution Analysis of Drugs, Druglikes, Metabolic Substances, and Antimicrobial Compounds , 2006, J. Chem. Inf. Model..
[15] H. Sahl,et al. The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.
[16] R. Hancock,et al. Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.
[17] U. Theuretzbacher,et al. Nature's clarion call of antibacterial resistance: are we listening? , 2006, Current opinion in investigational drugs.
[18] Artem Cherkasov,et al. Can 'Bacterial-Metabolite-Likeness' Model Improve Odds of 'in Silico' Antibiotic Discovery? , 2006, J. Chem. Inf. Model..
[19] J. Oppenheim,et al. Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.
[20] Kai Hilpert,et al. High-throughput generation of small antibacterial peptides with improved activity , 2005, Nature Biotechnology.
[21] R. Geffers,et al. A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance , 2005, Journal of bacteriology.
[22] Robert E W Hancock,et al. Design of host defence peptides for antimicrobial and immunity enhancing activities. , 2005, Combinatorial chemistry & high throughput screening.
[23] Håvard Jenssen,et al. Modelling of anti‐HSV activity of lactoferricin analogues using amino acid descriptors , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[24] Y. Kaznessis,et al. Protegrin structure–activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity , 2005, Peptides.
[25] Artem Cherkasov. Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks , 2005 .
[26] J. Powers,et al. Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] Artem Cherkasov,et al. Inductive Electronegativity Scale. Iterative Calculation of Inductive Partial Charges , 2003, J. Chem. Inf. Comput. Sci..
[28] S. Projan,et al. Why is big Pharma getting out of antibacterial drug discovery? , 2003, Current opinion in microbiology.
[29] J. Shimada,et al. In Vivo Antibacterial Activity of S-3578, a New Broad-Spectrum Cephalosporin: Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Experimental Infection Models , 2003, Antimicrobial Agents and Chemotherapy.
[30] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[31] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[32] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[33] Robert E W Hancock,et al. Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.
[34] J. Svendsen,et al. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors , 2001, Journal of peptide science : an official publication of the European Peptide Society.
[35] Robert E. W. Hancock,et al. Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide , 1999, Antimicrobial Agents and Chemotherapy.
[36] R. Hancock,et al. Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.
[37] J. Hansan. The end of an era. , 1996, Journal of aging & social policy.
[38] R. Hancock,et al. Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae , 1991, Antimicrobial Agents and Chemotherapy.
[39] M Bolognesi,et al. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. , 1988, The Journal of biological chemistry.